Enbridge Inc
ENB
Choice Properties Real Estate Investment Trust
CHP.UN
Brookfield Renewable Partners LP
BEP.UN
The Toronto-Dominion Bank
TD
TC Energy Corp
TRP
CA Stock MarketDetailed Quotes
INNO InnoCan Pharma Corp
- 0.185
- -0.010-5.13%
15min DelayMarket Closed Dec 20 10:38 ET
53.08MMarket Cap-15.42P/E (TTM)
0.190High0.185Low6.00KVolume0.190Open0.195Pre Close1.14KTurnover0.34052wk High0.00%Turnover Ratio286.94MShares0.18052wk Low-0.012EPS TTM41.01MFloat Cap1.650Historical HighLossP/E (Static)221.67MShs Float0.050Historical Low-0.023EPS LYR2.56%Amplitude--Dividend TTM7.12P/B1Lot Size--Div YieldTTM
InnoCan Pharma Corp Key Stats
EPS
According to the latest financial report of InnoCan Pharma Corp, the latest earnings per share (TTM) for the company is -0.00. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about InnoCan Pharma Corp's free cash flow? The latest report shows it as -1.01M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of InnoCan Pharma Corp shows that the company's current ratio is 3.57, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of InnoCan Pharma Corp, the quick ratio is 2.17, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of InnoCan Pharma Corp? The latest ROE figure is -5.81%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of InnoCan Pharma Corp, the total asset return on investment (ROA) is -3.17%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check InnoCan Pharma Corp's latest financial report to see how their gross margin is doing - currently at 90.20%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of InnoCan Pharma Corp, the net profit margin is 3.29%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.